Insulin isophane
Trade nomen medicamento: Insulin-isophane humano genere machinator (Insulinum humanum isophan-metabolic)
Internationalis nonproprietary nomen tuum: Insulin Isophane +
Forma; Suspensio telae ad administrationem
Substantiae agentis; + Insulin isophane
Pharmacotherapeutic coetus, medium agendi insulin-
Modus agendi:
An insulin mediocris apparatu eamque modicam. Per sanguinem GLYCOSA retrahitur minuatur, fibris augetur ejus intellectus, et crescit adipogenesis glikogenogenez, interdum synthesis, et reduces de GLYCOSA productio rate in iecur.
Interacts specifica receptores, apud exteriorem membranam cell formas, et universa insulinretseptorny. Activation synthesis in castris (in thalamis et adipem iecoris cellulis) directe vel penetrare in cellula (musculus) insulinretseptorny universa incitat intracellular causis, inter quas summam complectitur de key numerum enzymes (hexokinase, Ricinus communis, glycogen et aliis.). De reductione GLYCOSA in sanguinem incremento est debitum ad de intracellular transport, absorption quod assimilation TEXTUS amplificationem, titillatione lipogenesis, glikogenogeneza, interdum synthesis decrescet quam hepatis GLYCOSA productio rate (diminutio naufragii glycogen), et aliis.
Postquam p / infusum est actio intra 1-1.5 h Maximum effectum -. Inter 4-12 horae spatio - 11-24 h fretus compositionem et in pondere insulin-eventus significant inter- et vnutripersonalnye errorum propulsare valeat.
Signa in usu:
Typus I diabete Mellitus.
Type II diabetes Mellitus, gradu quocunque resistente et oralis hypoglycemic medicamento, sine certamine concessuros pars oralis hypoglycemic medicinae (compositum Lorem), incursat morbo, chirurgicam interveniret (mono- vel compositum Lorem), graviditatem in background de diabete (pauperes victu).
contraindications:
Hypersensitivity, hypoglycemia, insulinoma.
Forma atque administratio;
N / a, 1-2 temporibus per diem 30-45 minutes ante prandium (iniectio site mutata omni tempore). In casibus speciali, medicus ut praescribere / m infusum est præparátio ejus. B / medium agendi insulin-prohibitus sit? Lego singulis pendent doses GLYCOSA in sanguinem urina habet morbus. Vestibulum facilisis mollis portione medicatur non 8-24 I tempus per diem III. In adultis et filii sunt insulin sensus potest esse sat magno pondere saltem VIII III / die in patientibus reducta anima trahitur - III excedit XXIV / die. Cum cotidie dose maior quam III 0.6 / kg - in forma duo injections ad diversas sites. Accepto aegris C plus III aut per diem cum repositoque insulin in nosocomio. Translationem ab uno medicamento aliis. Si autem sub potestate GLYCOSA in sanguinem.
Latus effectus:
Cum violationes de dosing solo curandum est, victu, corporalis operatio gravibus concomitanter morbo potest develop hypoglycemia in pluribus casibus gravibus - prekomatosnoe et COMA.
Forsitan, allergic reactiones, locus - rubor et prurigine, generali - anaphylactoid profectae.
Commercio cum aliis medicinae:
Pharmaceutically compatible cum aliis solutions. AM. Hypoglycemic actio Amplify sulfonamides (oralis hypoglycemic comprehendo medicinae, sulfonamides), MAO inhibitors (including furazolidone, procarbazine, selegiline), carbonic anhydrase inhibitors, ACE inhibitors, NSAIDs (including salicylates), anabolic steroids (including stanozolol, oxandrolone, methandrostenolone), androgens, bromocriptine, tetracyclines, clofibrate, ketoconazole, mebendazole, theophylline, cyclophosphamide, fenfluramine parari + Li, Pyridoxinum, quinidine, quinine, chloroquine, ethanol. Hypoglycemic effectus minus firmae glucagon, incrementum hormone, corticosteroids, oralis contraceptives, estrogens, thiazide et loop urinam cient, BCCI, thyroid Hormones heparin, sulfinpyrazone, sympathomimetics, danazol, tricyclics, clonidine, calcium antagonistis suscipiunt, diazoxide, MORPHINUM, Marijuana, consectetuer, phenytoin, epinephrine, receptor-blockers et histamine H1.
Beta-blockers, reserpine, octreotide, pentamidine augendae utrumque potest reducere insulin hypoglycemic effectum.
Repono conditionibus comparandum habeant:
In refrigerator ad temperies 2-8 ° C (non duratus). Procul arceat puerorum.
Fasciae vita: II annis
Ne ultra expirata typis tellus.
Medicamentariorum conditiones copia; solet exercere
producentis: ICN Jugoslavija, Yugoslavia
